TH173927A - Pan-ELR + CXC CHEMOKINE antibody - Google Patents
Pan-ELR + CXC CHEMOKINE antibodyInfo
- Publication number
- TH173927A TH173927A TH1501005445A TH1501005445A TH173927A TH 173927 A TH173927 A TH 173927A TH 1501005445 A TH1501005445 A TH 1501005445A TH 1501005445 A TH1501005445 A TH 1501005445A TH 173927 A TH173927 A TH 173927A
- Authority
- TH
- Thailand
- Prior art keywords
- inflammatory
- antibodies
- cancer
- autoimmune diseases
- pustulosis
- Prior art date
Links
- 102000004965 antibodies Human genes 0.000 title claims abstract 10
- 108090001123 antibodies Proteins 0.000 title claims abstract 10
- 108050006947 CXC chemokine Proteins 0.000 title claims abstract 3
- 102000019388 CXC chemokine Human genes 0.000 title claims abstract 3
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims abstract 8
- 200000000018 inflammatory disease Diseases 0.000 claims abstract 8
- 206010003816 Autoimmune disease Diseases 0.000 claims abstract 6
- 206010033128 Ovarian cancer Diseases 0.000 claims abstract 4
- 206010038389 Renal cancer Diseases 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 4
- 201000010982 kidney cancer Diseases 0.000 claims abstract 4
- 201000004681 psoriasis Diseases 0.000 claims abstract 4
- 108010012236 Chemokines Proteins 0.000 claims abstract 2
- 102000019034 Chemokines Human genes 0.000 claims abstract 2
- 206010035148 Plague Diseases 0.000 claims abstract 2
- 241000607479 Yersinia pestis Species 0.000 claims abstract 2
- 230000001363 autoimmune Effects 0.000 claims abstract 2
- 101700075102 CXCL2 Proteins 0.000 claims 1
- 102100009664 CXCL2 Human genes 0.000 claims 1
- 101700012002 CXCL5 Proteins 0.000 claims 1
- 102100009682 CXCL5 Human genes 0.000 claims 1
- 101700033050 CXCL6 Proteins 0.000 claims 1
- 102100009685 CXCL6 Human genes 0.000 claims 1
- 108010014419 Chemokine CXCL1 Proteins 0.000 claims 1
- 102000016950 Chemokine CXCL1 Human genes 0.000 claims 1
- 101700048391 GCP2 Proteins 0.000 claims 1
- -1 Gro-gamma Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 101710042084 NAP1L4 Proteins 0.000 claims 1
- 101710030036 PPBP Proteins 0.000 claims 1
- 102100009687 PPBP Human genes 0.000 claims 1
- 101710037010 TUBGCP2 Proteins 0.000 claims 1
Abstract
แก้ไขใหม่ 8/9/2560 แอนติบอดี้ (antibodies) ถูกจัดเตรียม human ELR+ CXC chemokines เจ็ดชนิดยึดจับ อย่างจำเพาะ แอนติบอดี้ของการประดิษฐ์มีประโยชน์สำหรับการรักษาโรคอักเสบ/ออโต้อิมมูน (inflammatory/autoimmune diseases) ต่างๆ เช่น inflammatory bowel disease (IBD), plaque psoriasis และ palmoplantar(สูตร)pustulosis; และมะเร็ง เช่น มะเร็งไต หรือมะเร็งรังไข่ ------------------------------------------------------------------------- (เดิม) คำขอใหม่ปรับปรุงวันที่ 3/03/2559 แอนติบอดี้ (antibodies) ถูกจัดเตรียม human ELR + CXC chemokines เจ็ดชนิดอย่างจำเพาะ แอนติบอดี้ของการประดิษฐ์นี้มีประโยชน์สำหรับการรักษาโรคอักเสบ/ออโต้อิมมูน (inflammatory/autoimmune diseases) ต่างๆ เช่น inflammatory bowel disease (IBD), plague psoriasis และ palmoplamtar pustulosis; และ cancer เช่น renal cancer หรือ ovarian cancer New revision 8/9/2017 Antibodies were provided seven types of human ELR + CXC chemokines. Specifically, the invention antibodies are useful for the treatment of inflammatory / autoimmune diseases. (inflammatory / autoimmune diseases) such as inflammatory bowel disease (IBD), plaque psoriasis and palmoplantar (formula) pustulosis; And cancers such as kidney cancer or ovarian cancer -------------------------------------------------- ----------------------- (Old) New Request Updated 03/03/2016 Antibodies (human ELR + CXC) seven specific chemokines The antibodies of this invention are useful for the treatment of inflammatory disease / autoimmune. (inflammatory / autoimmune diseases) such as inflammatory bowel disease (IBD), plague psoriasis and palmoplamtar pustulosis; And cancer such as renal cancer or ovarian cancer.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH173927A true TH173927A (en) | 2018-03-08 |
| TH1501005445A TH1501005445A (en) | 2018-03-08 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017005388A2 (en) | Heterodimeric antibodies that bind to cd3 and tumor antigens | |
| NZ711704A (en) | Pan-elr+ cxc chemokine antibodies | |
| ES2543174T3 (en) | Medicinal composition for the treatment and / or prevention of cancer | |
| CY1123589T1 (en) | ANTIBODIES THAT BIND IL-23 | |
| EA202091540A1 (en) | ANTIBODIES TO LILRB2 | |
| PE20190737A1 (en) | ANTI-CD27 ANTIBODIES | |
| PE20180798A1 (en) | CONSTRUCTS OF BIESPEFIC ANTIBODIES THAT BIND MESOTHELIN AND CD3 | |
| EA201790288A1 (en) | ANTI-CTLA4 MONOCLONAL ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT, PHARMACEUTICAL COMPOSITION AND APPLICATION | |
| CO2019013935A2 (en) | Antibodies that specifically bind to pd-1 and methods of use | |
| NZ723858A (en) | Anti-human ox40l antibodies, uses & methods | |
| EA201591478A1 (en) | BISPECIFIC ANTIBODIES AGAINST TNF and IL-17 | |
| CL2020002225A1 (en) | Use of anti-il-36r antibodies for the treatment of inflammatory bowel disease | |
| MX2017001959A (en) | Antibodies specific for mmp9. | |
| EA201591974A1 (en) | HUMAN ANTIBODIES CONNECTING WITH RSV G-PROTEIN | |
| EA201591113A1 (en) | ANTIBODIES AGAINST ANTIGEN 2 BLOOD DENDRITIC CELLS AND THEIR APPLICATION | |
| CY1123116T1 (en) | THERAPEUTIC TREATMENT OF AUTOIMMUNE DISORDERS WITH CD154 ANTIBODIES | |
| EA202090401A1 (en) | ANTI-TIM-3 ANTIBODIES AND THEIR APPLICATION | |
| EA201892440A1 (en) | ANTIBODIES TO TL1A AND THEIR APPLICATIONS | |
| MX2020009130A (en) | Therapeutic anti-spla2-gib antibodies and the uses thereof. | |
| EA201692482A1 (en) | METHODS OF TREATMENT OF DISEASES BY ANTIBODIES THAT BIND THE RECEPTOR OF COLONYSTIMULATING FACTOR 1 (CSF1R) | |
| JP2017532332A5 (en) | ||
| EA202192488A1 (en) | ANTIBODIES AGAINST TSG-6 AND THEIR APPLICATIONS | |
| TH173927A (en) | Pan-ELR + CXC CHEMOKINE antibody | |
| CO2019002550A2 (en) | Anti-gm-csf antibodies and uses thereof | |
| EA201990493A1 (en) | ANTIBODIES TO GM-KSF AND THEIR APPLICATIONS |